Search research articles
Contact Us
Filters
Showing results (161-170 of 242) with videos related to
Page
of 25
Sort By:
American Journal of Respiratory and Critical Care Medicine
|
June 12, 2004
Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia
Esther S Choi, Claudia Jakubzick, Kristin J Carpenter, et al.
Journal of Clinical Pathology
|
April 29, 2004
Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia
C Jakubzick, E S Choi, S L Kunkel, et al.
Scientific Reports
|
July 23, 2020
Identification of a unique temporal signature in blood and BAL associated with IPF progression
Katy C Norman, David N O'Dwyer, Margaret L Salisbury, et al.
BMC Pulmonary Medicine
|
March 16, 2020
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
Jamie L Todd, Richard Vinisko, Yi Liu, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 6, 2016
Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias
Eric S White, Meng Xia, Susan Murray, et al.
The American Journal of Pathology
|
May 27, 2004
Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia
Claudia Jakubzick, Esther S Choi, Kristin J Carpenter, et al.
Chest
|
October 13, 2016
Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease
Jamie S Sheth, John A Belperio, Michael C Fishbein, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 22, 2007
An essential role for fibronectin extra type III domain A in pulmonary fibrosis
Andrés F Muro, Federico A Moretti, Bethany B Moore, et al.
The European Respiratory Journal
|
December 15, 2010
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
S L Schmidt, A M Nambiar, N Tayob, et al.
The New England Journal of Medicine
|
October 14, 2011
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis
Luca Richeldi, Ulrich Costabel, Moises Selman, et al.
Page
of 25
Search research articles
Search
Showing results (161-170 of 242) with videos related to
Sort By:
Page
of 25
American Journal of Respiratory and Critical Care Medicine
|
June 12, 2004
Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia
Esther S Choi, Claudia Jakubzick, Kristin J Carpenter, et al.
Journal of Clinical Pathology
|
April 29, 2004
Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia
C Jakubzick, E S Choi, S L Kunkel, et al.
Scientific Reports
|
July 23, 2020
Identification of a unique temporal signature in blood and BAL associated with IPF progression
Katy C Norman, David N O'Dwyer, Margaret L Salisbury, et al.
BMC Pulmonary Medicine
|
March 16, 2020
Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
Jamie L Todd, Richard Vinisko, Yi Liu, et al.
American Journal of Respiratory and Critical Care Medicine
|
May 6, 2016
Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias
Eric S White, Meng Xia, Susan Murray, et al.
The American Journal of Pathology
|
May 27, 2004
Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia
Claudia Jakubzick, Esther S Choi, Kristin J Carpenter, et al.
Chest
|
October 13, 2016
Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease
Jamie S Sheth, John A Belperio, Michael C Fishbein, et al.
American Journal of Respiratory and Critical Care Medicine
|
December 22, 2007
An essential role for fibronectin extra type III domain A in pulmonary fibrosis
Andrés F Muro, Federico A Moretti, Bethany B Moore, et al.
The European Respiratory Journal
|
December 15, 2010
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
S L Schmidt, A M Nambiar, N Tayob, et al.
The New England Journal of Medicine
|
October 14, 2011
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis
Luca Richeldi, Ulrich Costabel, Moises Selman, et al.
Page
of 25